Eli Lilly Total Long Term Liabilities 2012-2026 | LLY

Eli Lilly total long term liabilities for the quarter ending March 31, 2026 were $50.713B, a 40.61% increase year-over-year.

  • Eli Lilly total long term liabilities for 2025 were $50.713B, a 40.61% increase from 2024.
  • Eli Lilly total long term liabilities for 2024 were $36.067B, a 39.53% increase from 2023.
  • Eli Lilly total long term liabilities for 2023 were $25.849B, a 19.81% increase from 2022.

Eli Lilly Total Long Term Liabilities 2012-2026 | LLY

  • Eli Lilly total long term liabilities for 2025 were $50.713B, a 40.61% increase from 2024.
  • Eli Lilly total long term liabilities for 2024 were $36.067B, a 39.53% increase from 2023.
  • Eli Lilly total long term liabilities for 2023 were $25.849B, a 19.81% increase from 2022.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B